| Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap P Calabresi, M Di Filippo, V Ghiglieri, N Tambasco, B Picconi The Lancet Neurology 9 (11), 1106-1117, 2010 | 443 | 2010 |
| Levodopa in Parkinson's disease: current status and future developments N Tambasco, M Romoli, P Calabresi Current neuropharmacology 16 (8), 1239-1252, 2018 | 280 | 2018 |
| Cerebrospinal fluid lysosomal enzymes and alpha‐synuclein in Parkinson's disease L Parnetti, D Chiasserini, E Persichetti, P Eusebi, S Varghese, ... Movement Disorders 29 (8), 1019-1027, 2014 | 275 | 2014 |
| Cerebrospinal fluid biomarkers in Parkinson disease L Parnetti, A Castrioto, D Chiasserini, E Persichetti, N Tambasco, ... Nature Reviews Neurology 9 (3), 131-140, 2013 | 260 | 2013 |
| Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies L Parnetti, P Tiraboschi, A Lanari, M Peducci, C Padiglioni, C D'Amore, ... Biological psychiatry 64 (10), 850-855, 2008 | 219 | 2008 |
| Cerebrospinal fluid Tau/α‐synuclein ratio in Parkinson's disease and degenerative dementias L Parnetti, D Chiasserini, G Bellomo, D Giannandrea, C De Carlo, ... Movement Disorders 26 (8), 1428-1435, 2011 | 199 | 2011 |
| Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease L Parnetti, L Farotti, P Eusebi, D Chiasserini, C De Carlo, D Giannandrea, ... Frontiers in aging neuroscience 6, 53, 2014 | 194 | 2014 |
| Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in Parkinson's disease patients L Parnetti, S Paciotti, P Eusebi, A Dardis, S Zampieri, D Chiasserini, ... Movement Disorders 32 (10), 1423-1431, 2017 | 151 | 2017 |
| Validation of the Italian version of the movement disorder society—unified Parkinson’s disease rating scale A Antonini, G Abbruzzese, L Ferini-Strambi, B Tilley, J Huang, ... Neurological Sciences 34, 683-687, 2013 | 149 | 2013 |
| Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia D Chiasserini, L Biscetti, P Eusebi, N Salvadori, G Frattini, S Simoni, ... Alzheimer's research & therapy 9, 1-12, 2017 | 118 | 2017 |
| Frequency and characterization of movement disorders in anti-IgLON5 disease C Gaig, Y Compta, A Heidbreder, MJ Marti, MJ Titulaer, Y Crijnen, B Högl, ... Neurology 97 (14), e1367-e1381, 2021 | 94 | 2021 |
| Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group G Defazio, A Berardelli, G Abbruzzese, V Coviello, F Carella, ... Journal of Neurology, Neurosurgery & Psychiatry 67 (5), 613-619, 1999 | 84 | 1999 |
| Cerebrospinal fluid β-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies L Parnetti, C Balducci, L Pierguidi, C De Carlo, M Peducci, C D'Amore, ... Neurobiology of disease 34 (3), 484-486, 2009 | 83 | 2009 |
| Risk factors of levodopa-induced dyskinesia in Parkinson’s disease: results from the PPMI cohort P Eusebi, M Romoli, FP Paoletti, N Tambasco, P Calabresi, L Parnetti NPJ Parkinson's disease 4 (1), 33, 2018 | 82 | 2018 |
| Neurovascular territory involved in different etiological subtypes of ischemic stroke in the Perugia Stroke Registry M Paciaroni, G Silvestrelli, V Caso, F Corea, M Venti, P Milia, N Tambasco, ... European Journal of Neurology 10 (4), 361-365, 2003 | 69 | 2003 |
| Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study A Tessitore, P Marano, N Modugno, FE Pontieri, N Tambasco, M Canesi, ... Journal of neurology 265, 1124-1137, 2018 | 66 | 2018 |
| Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson’s disease patients G Gorgone, M Curro, N Ferlazzo, G Parisi, L Parnetti, V Belcastro, ... Neuromolecular medicine 14, 84-90, 2012 | 66 | 2012 |
| A case of vertebrobasilar stroke during oxygen-ozone therapy F Corea, S Amici, N Murgia, N Tambasco Journal of stroke and cerebrovascular diseases 13 (6), 259-261, 2004 | 64 | 2004 |
| Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy V Belcastro, L Pierguidi, N Tambasco Brain and Development 33 (4), 289-293, 2011 | 60 | 2011 |
| Magnetization transfer changes of grey and white matter in Parkinson's disease N Tambasco, GP Pelliccioli, P Chiarini, GE Montanari, F Leone, ... Neuroradiology 45, 224-230, 2003 | 60 | 2003 |
